Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Gut

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.41.1.8PMID 9274464PMCID PMC1027220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term prospective study ofHelicobacter pylori in nonulcer dyspepsia

  2005cited by this paper
• Helicobacter pylori — Von der Grundlage zur Therapie, Peter Malfertheiner (Ed.). Georg-Thieme-Verlag (1996), kart., DM 58.-

  1998cited by this paper
• Classification and Grading of Gastritis: The Updated Sydney System

  1997cited by this paper
• Efficacy and tolerability of a one‐week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer

  1997cited by this paper
• Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.

  1996cited by this paper
• Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

  1996cited by this paper
• Review of Helicobacter pylori eradication regimens.

  1996cited by this paper
• Digestive Disease Week and the 96th annual meeting of the American Gastroenterological Association. San Francisco, California, May 19-22, 1996. Abstracts.

  1996cited by this paper
• Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age

  1996cited by this paper
• Eradication of Helicobacter pylori in general practice

  1996cited by this paper
• Prospective screening of dyspeptic patients by Helicobacter pylori serology.

  1996cited by this paper
• Long-term consequences of Helicobacter pylori eradication: clinical aspects.

  1996cited by this paper
• Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.

  1996cited by this paper
• Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

  1996cited by this paper
• Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

  1996cited by this paper
• Helicobacter pylori eradication--a surrogate marker for duodenal ulcer healing.

  1996cited by this paper
• [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].

  1995cited by this paper
• One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.

  1995cited by this paper
• Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.

  1995cited by this paper
• Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group.

  1995cited by this paper
• Etiology of dyspepsia: four hundred unselected consecutive patients in general practice.

  1995cited by this paper
• Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

  1995cited by this paper
• Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.

  1995cited by this paper
• Prospective screening of dyspeptic patients by Helicobacter pylori serology.

  1995cited by this paper
• Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection

  1995cited by this paper
• The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study.

  1995cited by this paper
• Rapid eradication of Helicobacter pylori infection

  1995cited by this paper
• Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease

  1995cited by this paper
• Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori

  1994cited by this paper
• Possible role of Helicobacter pylori serology in reducing endoscopy workload.

  1994cited by this paper
• A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

  1994cited by this paper
• Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.

  1994cited by this paper
• Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.

  1993cited by this paper
• Screening for Helicobacter pylori antibody could reduce endoscopy workload in young dyspeptic patients

  1992cited by this paper
• Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

  1992cited by this paper
• Screening dyspepsia by serology to Helicobacter pylori.

  1991cited by this paper
• International Agency for Research on Cancer.

  1968cited by this paper

• In vitro study on anti-Helicobacter pylori effects of DL-3-n-butylphthalide-loaded silk fibroin nanoparticles

  2026cites this paper
• Molecular characteristics and Helicobacter pylori infection rates in patients with gastric cancer in Western Poland: a comparative analysis of gastrectomy specimens across two decades.

  2026cites this paper
• Efficacy and cost-effectiveness analysis of 10-day versus 14-day eradication of Helicobacter pylori infection with vonoprazan amoxicillin: a prospective, multicenter, randomized controlled trial

  2025cites this paper
• Actualización en el manejo terapéutico de infección por Helicobacter pylori

  2025cites this paper
• Should Metronidazole Be Included in Second‐Line Treatment After Standard Triple Therapy for Helicobacter pylori ?: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  2025cites this paper
• Diagnosis and treatment of Helicobacter pylori infection: past, present, and future.

  2025cites this paper
• Efficacy and safety of Qingwei Zhitong pellets combined with bismuth quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial

  2025cites this paper
• High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota

  2025cites this paper
• The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh

  2024cites this paper
• Long-term changes in the gut microbiota before and after bismuth quadruple therapy or concomitant therapy in children with peptic ulcers receiving Helicobacter pylori eradication

  2024cites this paper
• Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update

  2024cites this paper
• Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings

  2024cites this paper
• Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review.

  2024cites this paper
• Impact of Helicobacter pylori Eradication on Surgical Treatment of Peptic Ulcer Disease: Systematic Review

  2024cites this paper
• Helicobacter pylori Infection: A 40-Year Journey through Shifting the Paradigm to Transforming the Management

  2024cites this paper
• Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments

  2023cites this paper
• Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review

  2023cites this paper
• Focusing on Helicobacter pylori infection in the elderly

  2023cites this paper
• Is hybrid therapy more efficient in the eradication of Helicobacter pylori infection? A systematic review and meta-analysis

  2023cites this paper
• Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection

  2023cites this paper
• Determination of Helicobacter pylori resistance to clarithromycin in biopsy samples of gastric mucosa using TaqMan® MGB probes

  2023cites this paper
• The impacts of probiotics in eradication therapy of Helicobacter pylori

  2022cites this paper
• Helicobacter pylori culture: from bench to bedside

  2022cites this paper
• [The history of the discovery of the Helicobacter pylori].

  2022cites this paper
• Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure

  2022cites this paper
• The efficacy of bismuth quadruple therapy, sequential therapy, and hybrid therapy as a first-line regimen for Helicobacter pylori infection compared with standard triple therapy

  2022cites this paper
• Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?

  2022cites this paper
• Selective H2S gas sensors based on ohmic hetero-interface of Au-functionalized WO3 nanowires

  2022cites this paper
• GASTRIC CANCER IN YOUNG PATIENTS WITH NO ALARM SYMPTOMS: FOCUS ON DELAY IN DIAGNOSIS

  2022cites this paper
• TCM-Based Therapy as a Rescue Therapy for Re-Eradication of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis

  2022cites this paper
• Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)

  2022cites this paper
• Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial

  2022cites this paper
• Comparative Effectiveness of Various Eradication Regimens for Helicobacter Pylori Infection in the Northeastern Region of Poland

  2022cites this paper
• Helicobacter Pylori Colonization Density is an Important Risk Factor for Eradication Therapy.

  2022cites this paper
• A Review on Helicobacter pylori Infection

  2022cites this paper
• POSSIBILITIES OF COMPLEX CORRECTION OF MORPHOLOGICAL GASTRODUODENAL CHANGES WITH COMORBIDITY OF CHRONIC PANCREATITIS AND CHRONIC H. PYLORI - GASTRITIS.

  2021cites this paper
• Serological Biomarker Test (GastroPanel®) in the Diagnosis of Functional Gastric Disorders, Helicobacter pylori and Atrophic Gastritis in Patients Examined for Dyspeptic Symptoms

  2021cites this paper
• High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions

  2021cites this paper
• An Overview of Helicobacter pylori Infection.

  2021cites this paper
• Eficacia de la terapia dual para erradicación de H. pylori en una población colombiana

  2021cites this paper
• Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations

  2021cites this paper
• Culture-Based Antimicrobial Susceptibility Testing for Helicobacter pylori.

  2021cites this paper
• Prevalence of Helicobacter pylori infection in China: A systematic review and meta‐analysis

  2021cites this paper
• Progress in the practice

  2021cites this paper
• Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020

  2021cites this paper
• СОВРЕМЕННОЕ РАЗВИТИЕ СХЕМ ЭРАДИКАЦИИ HELICOBACTER PYLORI

  2021cites this paper
• Clinical audit of current Helicobacter pylori treatment outcomes in Singapore

  2021cites this paper
• Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori

  2021cites this paper
• The efficacy of dual therapy for eradicating H. pylori in a Colombian population

  2021cites this paper
• Helicobacter pylori Infection in Geriatric Patients: Current Situation and Treatment Regimens

  2021cites this paper
• Levofloxacin‐based Helicobacter pylori eradication in chronic dyspepsia

  2021cites this paper
• The Effect of Helicobacter pylori Eradication on Gastric Wall Thickness in Patients Undergoing Laparoscopic Sleeve Gastrectomy

  2021cites this paper
• Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030.

  2021cites this paper
• Treatment and Drug Resistance to Helicobacter Pylori: A Brief Review

  2021cites this paper
• AGA Clinical Practice Update on The Management of Refractory Helicobacter pylori Infection: Expert Review

  2021cites this paper
• Dyspepsia Challenge in Primary Care Gastroenterology

  2021cites this paper
• Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape

  2021cites this paper
• Effect of mupirocin in Helicobacter pylori in vitro

  2021cites this paper
• The current role of dual therapy for treatment of Helicobacter pylori: back to the future?

  2020cites this paper
• A Comparison of Accuracy between IMMULITE2000® and GENEDIA® for Helicobacter pylori Infection

  2020cites this paper
• Comparison of four different regimens against Helicobacter pylori as a first‐line treatment: A prospective, cross‐sectional, comparative, open trial in Chinese children

  2020cites this paper
• High-Dose Dual Therapy versus Triple Therapy for Treatment of H. Pylori Infection: A Parallel Randomized Study

  2020cites this paper
• Helicobacter Pylori Eradication by Levofloxacin Based Triple Therapy in Patients with Peptic Ulcer Disease

  2020cites this paper
• Helicobacter pylori Infection and Atrophic Corpus Gastritis on Patients with Intellectual Disability: Challenges in the Clinical Translation of Personalized Medicine

  2020cites this paper
• Can Hybrid Therapy Be an Alternative to the First-line Regimen for Helicobacter pylori Infection?

  2020cites this paper
• Cholesterol glucosylation–based survival strategy in Helicobacter pylori

  2020cites this paper
• The Benefits of Non-Surgical Periodontal Treatment in Association with Gastric Eradication

  2020cites this paper
• Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database.

  2020cites this paper
• The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment

  2020cites this paper
• A Prospective study of role of triple therapy in control of Helicobacter Pylori infection in peptic ulcer disease

  2020cites this paper
• Transitioning of Helicobacter pylori Therapy from Trial and Error to Antimicrobial Stewardship

  2020cites this paper
• Efficacy and Safety of Modified Dual Therapy as the First-line Regimen for the Treatment of Helicobacter pylori Infection

  2020cites this paper
• Long‐term changes in the gut microbiota after 14‐day bismuth quadruple therapy in penicillin‐allergic children

  2020cites this paper
• Helicobacter pylori (Hp) IgG ELISA of the New-Generation GastroPanel® Is Highly Accurate in Diagnosis of Hp-Infection in Gastroscopy Referral Patients

  2020cites this paper
• The Effect of Helicobacter pylori Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies

  2020cites this paper
• Triple‐nanostructuring‐based noninvasive electro‐immune sensing of CagA toxin for Helicobacter pylori detection

  2020cites this paper
• Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance

  2020cites this paper
• European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

  2020cites this paper
• Diagnostic yield of upper endoscopy according to appropriateness: A systematic review.

  2019cites this paper
• Helicobacter pylori Infection following Endoscopic Resection of Early Gastric Cancer

  2019cites this paper
• Evaluation of diagnostic and treatment strategies for the management of Helicobacter pylori infection

  2019cites this paper
• How can Helicobacter pylori eradication therapies be improved ?

  2019cites this paper
• GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review

  2019cites this paper
• Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori

  2019influential citation
• Treating Helicobacter pylori infection in the face of growing antibiotic resistance.

  2019cites this paper
• Influence of serum vitamin D level on Helicobacter pylori eradication: A multi‐center, observational, prospective and cohort study

  2019cites this paper
• Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)

  2019cites this paper
• Synergistic effect of 2D material coated Pt nanoparticles with PEDOT polymer on electrode surface interface for a sensitive label free Helicobacter pylori CagA(Ag-Ab) immunosensing.

  2019cites this paper
• Helicobacter Pylori Eradication - A New Look at Old Problems

  2019cites this paper
• Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies.

  2019cites this paper
• Prevention of overuse: A view on upper gastrointestinal endoscopy

  2019cites this paper
• Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study

  2019cites this paper
• Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions

  2019cites this paper
• Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.

  2019cites this paper
• Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?

  2019cites this paper
• Helicobacter pylori antimicrobial resistance during a 5‐year period (2013‐2017) in northern Spain and its relationship with the eradication therapies

  2018cites this paper
• Smoking and Drinking Did Not Increase the Failure of Therapeutic Helicobacter pylori Eradication by Vonoprazan, Clarithromycin, and Amoxicillin

  2018cites this paper
• Is There a Role for the Non-Helicobacter pylori Bacteria in the Risk of Developing Gastric Cancer?

  2018cites this paper
• Helicobacter pylori eradication: influence of interleukin-1beta –31 C/T polymorphism

  2018cites this paper
• Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study

  2018cites this paper